U.S. Clinical Trial: Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Deucravacitinib Rosacea

Press/Media

Period1 Aug 2024

Media coverage

1

Media coverage

  • TitleU.S. Clinical Trial: Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Deucravacitinib Rosacea
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date1/08/24
    PersonsBenjamin Ungar